FourThought Financial’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$8.1M Buy
35,925
+386
+1% +$93.6K 1.2% 23
2022
Q2
$8.65M Sell
35,539
-542
-2% -$133K 1.26% 19
2022
Q1
$8.75M Sell
36,081
-82
-0.2% -$18.8K 1.11% 25
2021
Q4
$8.14M Buy
36,163
+1,134
+3% +$239K 1.02% 26
2021
Q3
$7.45M Buy
35,029
+900
+3% +$207K 0.99% 26
2021
Q2
$8.32M Sell
34,129
-761
-2% -$187K 1.11% 26
2021
Q1
$8.68M Buy
34,890
+540
+2% +$129K 1.26% 20
2020
Q4
$7.9M Buy
+34,350
New +$7.92M 1.26% 19

Other funds holding AMGN

FourThought Financial's AMGN Position: Q3 2022 in Review

FourThought Financial increased its Amgen (AMGN) stake by 1.1% in Q3 2022, buying an estimated $93.6K and bringing the position to 35,925 shares worth $8.1M. The position accounts for 1.2% of the portfolio, ranked #23.

FourThought Financial first reported a position in AMGN in Q4 2020 and has held it in 8 quarters since. The position peaked at $8.75M in Q1 2022. 2,323 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

  • FourThought Financial held 35,925 shares of Amgen worth $8.1M as of Q3 2022.
  • FourThought Financial bought 386 Amgen shares in Q3 2022, an estimated $93.6K.
  • Amgen made up 1.2% of FourThought Financial's portfolio in Q3 2022, its #23 holding.
  • FourThought Financial first reported a position in Amgen in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's Amgen position peaked at $8.75M in Q1 2022.
  • 2,323 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.